Your browser doesn't support javascript.
loading
The quantification of myotonia. A problem in the evaluation of new antimyotonic drugs.
J Neurol Sci ; 59(2): 167-73, 1983 May.
Article en En | MEDLINE | ID: mdl-6854347
ABSTRACT
The evaluation of an antimyotonic drug is often difficult since the severity of myotonia is itself hard to assess. The rise in arterial potassium level produced by the infusion of increasing concentrations of potassium chloride brought about reproducible changes in the excitability level of myotonic muscles proportional to the plasma potassium concentration. The excitability changes were assessed by three methods commonly used for evaluating antimyotonic drugs. The duration of the electromyographic relaxation time after maximal voluntary effort proved to be the only test which reliably assessed the variations of muscular excitability proportional to the increased plasma potassium. By contrast, the duration of percussion- or electrically-induced myotonic after-discharges was extremely variable and independent of plasma potassium.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Distrofia Miotónica Límite: Female / Humans / Male Idioma: En Revista: J Neurol Sci Año: 1983 Tipo del documento: Article
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Distrofia Miotónica Límite: Female / Humans / Male Idioma: En Revista: J Neurol Sci Año: 1983 Tipo del documento: Article